Navigation Links
Modulating the immune system to combat metastatic cancer
Date:5/24/2013

Cancer cells spread and grow by avoiding detection and destruction by the immune system. Stimulation of the immune system can help to eliminate cancer cells; however, there are many factors that cause the immune system to ignore cancer cells. Regulatory T cells are immune cells that function to suppress the immune system response. In this issue of the Journal of Clinical Investigation, researchers led by Ronald Levy at Stanford University found that regulatory T cells that infiltrate tumors express proteins that can be targeted with therapeutic antibodies. Mice injected with antibodies targeting the proteins CTLA-4 and OX-40 had smaller tumors and improved survival. Moreover, treatment with these antibodies cleared both tumors at the primary site and distant metastases, including brain metastases that are usually difficult to treat. These findings suggest that therapies targeting regulatory T cells could be a promising approach in cancer treatment. In an accompanying commentary, Cristina Ghirelli and Thorsten Hagemann emphasize that in order for this approach to be clinically relevant, it will be important to show that targeting regulatory T cells in metastatic tumors also blocks growth.


'/>"/>

Contact: Jillian Hurst
press_releases@the-jci.org
Journal of Clinical Investigation
Source:Eurekalert

Page: 1

Related biology news :

1. Portion of hippocampus found to play role in modulating anxiety
2. U of Alberta researcher steps closer to understand autoimmune diseases
3. UCI-led study uncovers how Salmonella avoids the bodys immune response
4. New insight into mechanisms behind autoimmune diseases suggests a potential therapy
5. Immune system implicated in prematurity complication
6. Key to immune system disease could lie inside the cheek
7. New immune defense enzyme discovered
8. New genetic mechanism of immune deficiency discovered
9. Carnegie Mellon fluorescent biosensor reveals mechanism critical to immune system amplification
10. Immune-response genes affecting breast tumor eradication
11. New screening technique yields elusive compounds to block immune-regulating enzyme
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/8/2019)... ... May 07, 2019 , ... ... Technology Council, an invitation-only community for world-class CIOs, CTOs, and technology executives. ... cold chain engineering firm that guarantees confidence in a company’s cold chain. ...
(Date:5/7/2019)... ... May 07, 2019 , ... Landsec and Spartan Bioscience ... the UK. , In May, Landsec will undertake trials using Spartan’s innovative Legionella ... operators to take corrective action within hours instead of weeks. This test, ...
(Date:5/2/2019)... ... May 01, 2019 , ... uBiome, ... appointed John Rakow, the Company’s General Counsel, as Interim Chief Executive Officer of ... are currently on administrative leave. There will also be an independent investigation into ...
Breaking Biology News(10 mins):
(Date:4/10/2019)... (PRWEB) , ... April 10, 2019 , ... After more ... upgrade. The new kitchen is equipped with updated appliances and modern lighting and ... La Jolla-based venue. , “We’ve seen tremendous growth in the demand for ...
(Date:4/9/2019)... (PRWEB) , ... April 09, 2019 , ... The ... incoming members of the Society's leadership team, including a new addition to the presidential ... five of their peers to join the Society's leadership team for a three-year term ...
(Date:4/8/2019)... ... April 09, 2019 , ... To support ... center Chan Zuckerberg Biohub (CZ Biohub) has chosen Geneious Biologics to help them ... of CZ Biohub’s efforts to establish new approaches to inform the discovery of ...
(Date:3/29/2019)... ... March 28, 2019 , ... Specific ... CARB-X has proceeded with a second stage of funding for Specific’s Reveal™ rapid ... is on top of the $1.7 million already awarded by CARB-X. The additional ...
Breaking Biology Technology: